key: cord-0828619-yi30n9zv authors: Johal, Kavan S; Vinnicombe, Zak; Khan, Umraz; Mohanna, Pari-Naz title: COVID-19 and plastic surgery: lessons from a national specialty review in the United Kingdom: COVID-19 and plastic surgery date: 2021-04-18 journal: J Plast Reconstr Aesthet Surg DOI: 10.1016/j.bjps.2021.03.109 sha: 8701742a81669542efab9bca60af492553848180 doc_id: 828619 cord_uid: yi30n9zv BACKGROUND: Ramifications of COVID-19 on the re-structuring of healthcare are widespread, including delivery of surgical services across all specialties including plastic surgery. Redeployment of personnel and cessation of elective services are commonplace. However, there is a continued need for both emergency and oncological surgery. A national review of practice was conducted during the COVID-19 pandemic, to assess impact on services, staffing and training. METHODS: Key aspects of current plastic surgery practice in the United Kingdom were examined in this cross-sectional study; operating capacity, location of theatre lists (national health service or outsourced private institutions), differences across sub-specialties, change in anaesthesia practices, staffing, redeployment, on-call provision and impact on training. RESULTS: Three-hundred and forty-four plastic surgeons in the United Kingdom provided practice data across 51 units. Theatre capacity and outpatient services were markedly reduced. Outsourcing of operating lists to private institutions was widely utilised. Increased use of local anaesthetic hand procedures, the prioritisation of shorter operations with reduced microsurgery in both head and neck/lower limb and almost complete cessation of breast reconstruction was noted, together with marked regional variations. Re-deployment occurred at all staffing levels, whilst telemedicine played a critical role in both patient management and training. CONCLUSIONS: COVID-19 has enforced unprecedented changes to surgical care delivery and training, as identified by examination of plastic surgery nationally in the United Kingdom. Novel means to support continued elective and emergency services including oncology have been identified. Lessons learned will allow phased return of services and improved preparation for the future. local anaesthetic hand procedures, the prioritisation of shorter operations with reduced microsurgery in both head and neck/lower limb and almost complete cessation of breast reconstruction was noted, together with marked regional variations. Re-deployment occurred at all staffing levels, whilst telemedicine played a critical role in both patient management and training. COVID-19 has enforced unprecedented changes to surgical care delivery and training, as identified by examination of plastic surgery nationally in the United Kingdom. Novel means to support continued elective and emergency services including oncology have been identified. Lessons learned will allow phased return of services and improved preparation for the future. At the time of writing, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 105,394,301 confirmed cases of coronavirus disease (COVID-19) (1). Of these, 3,929,839 have been confirmed in the United Kingdom alone (2). Entering into the realm of a pandemic (3) has had global consequences for healthcare delivery. An immediate need for equipment and personnel on the frontline (4) has directly impacted on the delivery of previously established surgical services. Plastic surgery is not unique in this domain. Redeployment of surgical staff (5) (of any grade), reduction or cessation of elective services and novel provisions for time-critical surgery (including cancer or trauma) are widespread (6) . The impact on patients and healthcare professionals must be ascertained. The reasons for this are numerous and include the need to provide a unified speciality response during the current pandemic (including potential re-introduction of services), the effects on staffing and training, but perhaps most importantly, planning the future of the speciality including its preparation for global events. Plastic surgery is unique in being surgically broad. However, during this time many units have been forced to re-evaluate services, separating essential from desirable activity. Where surgery cannot be delayed, logistical challenges may exist with respect to theatre and staff availability. Combined with national guidance towards shorter operations, the gold-standard of microvascular free flap reconstructions across all sub-specialties may have been directly impacted. To further delineate the effect on plastic surgery in the United Kingdom, a novel questionnaire was distributed in association with BAPRAS (British Association of Plastic Reconstructive and Aesthetic Surgeons) to all members within the United Kingdom. Furthermore, we reviewed updated COVID-19 guidelines across all sub-specialties, comparing this to current practice. An electronic questionnaire was designed to specifically focus on key areas of plastic surgery service delivery. This survey was conducted over a three-week period in May 2020. Basic demographic data was collated to include grade of responder and base unit. Current number and location of operating lists (across both NHS/private hospitals and specifically for sub-specialties including hand, skin, breast, lower limb, head and neck), type of anaesthesia, theatre utilisation, changes in reconstructive options utilised, management of outpatients, redeployment of staffing, changes in emergency service provision, use of information technology services and teaching were all evaluated. Any clinician reporting themselves to be shielding at this time was recorded. Data was collated and statistical analysis performed using Stata 15.1 (Timberlake Consultants Limited, London, UK). Descriptive statistics were used to report patterns across units and subspecialties. We assumed the rates within regions to have a Poisson distribution and used a test for overdispersion (heterogeneity) to examine whether regional differences were statistically significant. Updated guidelines from national plastic surgery bodies and sub-specialties were accessed for comparison against results. In total, 344 individuals responded across the United Kingdom. From these, 124 responses were removed for; inadequate completion (81), no unit information (15) and shielding (28). Of the remaining 220 responses, these represented a total of 63 plastic surgery units. Elective clinics were reported as: normal (4), restricted (37), not running (7) with the nature of these clinics either face-to-face (6), telephone (30), virtual (15) or a combination of all (5) . Hand clinics were reported as: restricted (15) , normal (27) , not running (8), with clinic frequency per week of: 1-5 (22), 7(12), >8 (7). All units reported benefit from IT support during the time of COVID-19. This was relatively equally distributed between Telemedicine (42), Teaching (41), Microsoft Teams (35) and a combination of all these (25) . Of the 43 trainees who responded, 31 provided meaningful data, 22 .5% had been redeployed whilst the remainder had not. Concerns over training issues were expressed by 81%, in particular indicative logbook numbers alone (32%) and also combined with workbased assessments (48%). Only 10% reported having no concerns. Forty-seven of 51 units continued provision of a hand trauma service. The location of these lists was split between NHS (31 units, 66%), NHS and private institution(PI) (12 units, 26%) and PI only (4 units, 9%) across units (Graph 1). The majority of units (43/50) confirmed paediatric trauma was still taking place, although a significant shift was seen in the location of these lists to adult emergency theatres, (59 and 41% in adult and paediatric theatres respectively). Seventy-four percent of units reported local anaesthetic or WALANT techniques were the most common anaesthetic type used, versus regional and general anaesthesia (15% and 11% of units respectively). Hand trauma theatres were the most commonly reported location for cases (13 units, 30%), followed by local procedure rooms (12 units, 28%), emergency departments (9 units, 21%) and CEPOD (9 units, 21%). Of 51 responding units, all but two reported continued provision of a skin cancer service. The location of these lists was split between NHS (23 units, 47%), NHS and PI (16 units, 33%) and PI only (10 units, 20%) (Graph 1). As a relative proportion of work undertaken, a larger volume of skin cancer operating was completed in private institutions relative to other subspecialties, although predominantly still being performed by NHS teams. With regards to management of nodal basins, 25 units (50%) were still performing sentinel node biopsy and 37 (74%) were still carrying out axillary dissections. Of those who felt able to comment, 88% reported meeting the two-week wait cancer pathway criteria. No correlation was noted between the unit size (represented by the number of consultants) and the mean number of lists per week at the time of this study, representing the effect of COVID-19 on unit capacity. emphasising bulk of operating capacity across hand trauma and skin cancer, with lower numbers for head and neck, lower limb reconstruction and extremely limited breast reconstruction. To further compare regional data, the mean number of lists per Consultant was extracted based on the total number of lists and Consultants per unit across the region. This information is shown in Graph 4 and reveals differences between regions were statistically significant (test for overdispersion, p<0.001). At the time of this study, the most up to date national COVID-19 guidelines across all plastic surgery sub-specialties were reviewed. A summary of this is presented in Table 1 . Exponential rise in worldwide community and hospital infections secondary to COVID-19 (3, 13, 14) has resulted in unprecedented challenges for healthcare service delivery. Plastic surgery services, in line with many other surgical specialties, have been significantly affected. This study has examined the national effect on an entire specialty and demonstrated severe restrictions in operating capacity, cross-level re-deployment, modified outpatient services and marked changes in reconstructive practices across all sub-specialties. Novel strategies to combat this have included outsourcing of lists to private institutions, most significantly in day-case surgery such as hand trauma and skin cancer. Outpatient management has been largely telephone or virtual-based. Absence of clinical examination may limit decisions on future management. However, it appears patients requiring immediate treatment (oncology or acute trauma) have continued to be seen. A testament to this is the high proportion (88%) who reported meeting the 2-week wait targets in skin cancer. Considering specific sub-specialties, significant logistical and intra-operative changes were implemented to allow continuation of urgent work. In hand trauma, a huge shift to local anaesthetic/WALANT was demonstrated (74% of all cases), in parallel to increased procedure-room (versus formal theatre) operating. Injuries traditionally deemed to require theatre utilisation have been safely treated in this manner. Advocates of WALANT (15, 16) would suggest this to be best practice even in non-pandemic times. However long-term data on patient outcomes is required with comparison of non-COVID matched cohorts. Within this study, only 50% of UK units were currently performing sentinel node biopsy for cutaneous malignancy. Given the extensive published trial data (17, 18) showing prognostic benefit, outcomes from this time period will provide opportunity to re-evaluate the importance of these adjunctive procedures. The relatively high number of units performing ongoing nodal dissection (74%) may represent small cohorts with advanced disease and the need for local surgical control. Of the microsurgical sub-specialties, breast reconstruction was most impacted during the COVID-19 outbreak. Total number of lists were nationally low, with only single cases of implant-based reconstruction and pedicled flaps, the majority being treated by mastectomy only. No free flap reconstructions were being performed. Globally, increasing numbers of patients have been stabilised on endocrine treatment, with a view to carrying out mastectomy with or without reconstruction at a later date (19) . This will generate expanding waiting lists for both immediate and delayed reconstruction, with associated logistical and financial implications. These concerns are not unique to plastic surgery and many healthcare institutions globally will be met with similar dilemmas. Considering other microsurgical subspecialties, lower limb and head and neck practices appear to be continuing, albeit at reduced capacity. The modal response was for 1-2 operating lists per week across both sub-specialties, with the majority in NHS institutions. However, reconstructive practices favoured increased use of local options (including pedicled flaps and grafts), with a majority prioritising shorter operations. In total, 15 (of 34) units were still performing free flaps in lower limb and 13 (of 29) units for head and neck. The net result of this in terms of functional and (to a lesser extent) aesthetic outcomes remains to be seen; high numbers requiring revisional surgery or late spikes in extremity deep infections may be of concern. Regional Data in the United Kingdom Regional comparisons identified numerous key factors. Large centres did not necessarily have more theatre capacity, perhaps a reflection on increased conversion of these units to COVID-19 medical hubs. There was significant regional variation in the numbers of lists and sub-specialty activity (Figure 3) . A large proportion of lists were devoted to hand trauma and skin cancer, a reflection on both volume of work, access to lists (including at private institutions) and the ability for local anaesthetic operating. Standardising regions by number of lists per consultant per week demonstrated that high population areas (such as London) (with correspondingly high incidence of COVID-19 infections) were most affected in terms of operating capacity (Figure 4) . Almost all units experienced re-deployment of personnel at all grades. This directly impacted trainees in particular, who expressed concern regarding indicative numbers required for progression and the ability to complete work-based assessments. This may also be a reflection on increased consultant-led operating during this time period combined with reduced operative exposure. With the likelihood of ongoing waves in the current pandemic, the imminent return to 'normal' levels of surgical activity is doubtful. Furthermore, the need to prioritise patient and staff health may result in further paired Consultant operating. Net results are likely to be negative for training within not only plastic surgery but across all specialities. This may necessitate re-evaluation of required competencies for completion of training and perhaps also extension of training time. Information technology clearly has a critical role to play during a pandemic; both in-patient care and for training healthcare professionals where usual clinical bedside or operative opportunities are lacking. Many institutions have reported on the use of telemedicine for triage (emergency and surgical) (20, 21) and outpatient services whilst online webinars have proved critical for ongoing education at all staff levels across a multitude of specialties (22) . Our own data confirmed widespread use of IT support (>80% of units) including telemedicine, Microsoft Teams or combinations of these. A clear need has been identified for future-proofing in the event of ongoing or new global healthcare crises. Increased staff training, preparation of pandemic response plans and dedicated theatres or hospitals for infected individuals have been suggested as potential strategies (6, 23) . Protocols for parallel continuation of clean surgery may be critical for maintaining standards of care in elective work (24) , including the potential use of ambulatory surgical centres (25) . These are likely to be fundamental to the reintroduction of elective surgery after an initial blanket ban proposed by national organisations (26) . Regular review of outcomes is required, particularly given early data suggesting higher postoperative pulmonary complications and mortality in COVID-positive patients (27) . This study has identified the response of plastic surgery as a specialty in the United Kingdom to a pandemic, which is likely to readily translate to other specialities and countries worldwide. It remains to be seen whether the delivery of plastic surgery services in the United Kingdom, or indeed globally, will return to pre COVID-19 levels. Microsurgical reconstruction, particularly the use of free flaps across all sub-specialties but especially breast reconstruction, has been greatly impacted. However, resilience has been demonstrated by the adaptation of limited resources to continue to care for the acute needs of our patients. Despite a pandemic, services for urgent oncology and acute trauma have continued to operate. Ongoing re-evaluation of surgical systems and patient outcomes is critical across all specialties at numerous time-points both during and post-crisis, as data such as our own provides only a single temporal window of the impact of COVID-19. Perhaps as a speciality, profession and a nation, we will feel better prepared for a future global health crisis. For now, the situation is fluid and we must continue to adapt to ensure we can continue to meet the needs of our patients and staff alike. WHO Coronavirus Disease (COVID-19) Dashboard Time to use the p-word? Coronavirus enters a dangerous new phase Plastic Surgeons in the Time of a Pandemicmic a dangerous new phase Whathat Pandemicmic a dangerous new phase.opaedic surgeon during the COVID-19 pandemic: perspectives from the trenches Managing COVIDVIDhat Pandemicmic a dangerous new phase British Orthopaedic Association Standards for Trauma and Orthopaedics. Management of patients with urgent orthopaedic conditions and trauma during the coronavirus pandemic Advice for managing BCC & SCC patients during Coronavirus pandemic Advice for managing Melanoma patients during Coronavirus pandemic British Association of Dermatologists and British Society for Dermatological Surgery. COVID-19 -Skin cancer surgery guidance Association of Breast Surgery. Statement from the Association of Breast Surgery A Novel Coronavirus from Patients with Pneumonia in China Clinical Characteristics of Coronavirus Disease 2019 in China Wide-awake flexor tendon repair How the wide awake tourniquet-free approach is changing hand surgery in most countries of the world Sentinel-Node Biopsy or Nodal Observation in Melanoma Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic Surgery Scheduling in a Crisis Virtually perfect? Telemedicine for COVID-19 Webinars in plastic and reconstructive surgery training-a review of the current landscape during the COVID-19 pandemic Global guidance for surgical care during the COVIDOVIDninga review of the curren Mitigating the risks of surgery during the COVID-19 pandemic. The Lancet Surviving the Covid-19 Pandemic: Surge Capacity Planning for Non-Emergent Surgery Covid-19: all non-urgent elective surgery is suspended for at least three months in England Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. The Lancet Figure Legends Graph 1: Location of operating lists across national health service (NHS) hospitals and private institutions Graph 2: Reconstruction types by sub-specialty Graph 3: Sub-specialty regional variation across UK regions Graph 4: Mean number of lists per consultant per week Ethical approval: Not required.